Allied Digestive Health

Home   >   Our Providers   >  Andrew M. Goldenberg, MD, FACP

Andrew M. Goldenberg, MD, FACP

Book Appointment
845-354-3700

Digestive Disease Associates of Rockland

Visit Digestive Disease Associates of Rockland
974 Route 45
Suite 2000
Pomona, NY 10970

Education

Bachelor’s Degree – Vanderbilt University

Medical Degree – Boston University

Internship – Boston City Hospital

Residency – Boston City Hospital

Fellowship – Mount Sinai Hospital

Board Certifications – Gastroenterology, Internal Medicine

Honors & Awards

  • Castle Connolly Top Doctors, 2018-present
  • AOA honors in medical school at Boston city Hospital
  • Graduated magma cum Laude from Vanderbilt

Specialties & Main Areas of Interest

  • All GI disorders

Hospital Affiliations

  • Good Samaritan
  • Montefiore Nyack Hospital

Other Appointments

  • Clinical Instructor, Mount Sinai Medical Center

Research

  • Goldenberg, A.M, Present, D.H., Bauer, J., Gordon, R. Islet Cell Tumor Presenting as Massive Upper Gastrointestinal Bleeding in Pregnancy. American Journal of Gastroenterology: 1988;83: 873-75
  • Goldenberg, A.M, Wexler, L.F. Quinine Overdose: Review of Toxicity and Treatment Clinical Cardiology 1988; II :716-18
  • Itzkowitz, S.H., Lee H, Hanauer S, Goldenberg, A.M, Kim, Y.S. New Biochemical Markers Associates with Dysplasia in Ulcerative Colitis Gastroenterology 1987;92 (5): 1449
  • Itzkowitz, S.H, Lee H, Hanauer, S, Goldenberg, A.M, Kim, Y.S. Cancer-Associated Alterations in Blood Group Antigen Expression Occurring in Ulcerative Colitis.
  • 2000 – Rabeprazole FAST trial (Janssen)
  • 2000 – A Twelve Week Randomized Double-Blind, Placebo Controlled Study of the Efficacy and Tolerability of Alosetron Hydrochloride 1 mg. Twice daily for the control of bowel urgency in females with non-constipated JBS in an Independent Practitioner Association Model. Protocol #S3B40051
  • 2000 – START: Standard Therapeutic Assessment of Rebetron Trial. Indiana University, Indiana Gastroenterology 1988;94 (5); 1449
  • 2000 – A Comparative Efficacy Study of Esomeprazole Magnesium (40 mg qd) and Lansoprazole (30mgs qd) in Patients with Erosive Esophagitis. Protocol #267
  • May 2001 – Completed: Roche Laboratories, Inc. A Prospective Randomized Multicenter, Open Label, Comparative Safety Study of Pegasys vs. Pegasys Plus Ribavirin in Treatment of Patients with Hep C “Wings Trial”.
  • March 2001 – Completed: Proctor & Gamble. Asacol 4.8gm/day vs 2.4 gm/day in mild to moderate ulcerative colitis patients experiencing an active flare.
  • April 2003 – Abbott Laboratories: A Multi-Center, Randomized, Double-Blind, Placebo­Controlled Study of Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects with Crohn’s Disease.
  • September 2003 – GlaxoSmithK.line-A 12-week, Randomized, Double-Blind, Placebo­ Controlled Study of PRN BID and Fixed Dosing Regimens of Alosetron in Female Subjects with Severe Diarrhea-Predominant Irritable Bowel Syndrome Who Have Failed Conventional Therapy.

Fun Facts

  • Dr. Goldenberg enjoys playing golf, fishing, exercising, and traveling. He also
    was a jazz lead trumpet player and has recorded three albums.

Conditions Treated

Procedures Performed

Appointment Locations